S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

NCT01925131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Acute Leukemias of Ambiguous Lineage
B-cell Adult Acute Lymphoblastic Leukemia
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Burkitt Lymphoma

Interventions

DRUG: cyclophosphamide
DRUG: vincristine sulfate
DRUG: prednisone
BIOLOGICAL: inotuzumab ozogamicin
OTHER: laboratory biomarker analysis

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]